SYDNEY, April 17, 2025 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop and commercialise ...
The copper isotope Cu-64 plays an important role in medicine: It is used in imaging processes and also shows potential for cancer therapy. However, it does not occur naturally and must be produced ...
Copper-64 positron emission tomography (PET) imaging has emerged as a pivotal modality in cancer research, offering unique insights into tumour biology by visualising copper metabolism and the ...
The copper isotope Cu-64 plays an important role in medicine: it is used in imaging processes and also shows potential for cancer therapy. However, it does not occur naturally and must be produced ...
Clarity has signed a commercial-scale agreement with Nusano, Inc. ("Nusano") for supply of copper-64 (Cu-64 or 64Cu) isotope. The 190,000 square foot Nusano facility in West Valley City, Utah is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results